{"id":3619,"date":"2026-09-04T09:15:43","date_gmt":"2026-09-04T07:15:43","guid":{"rendered":"https:\/\/www.amyloidosisalliance.org\/wetenschappelijk-comite\/"},"modified":"2026-11-03T08:38:44","modified_gmt":"2026-11-03T07:38:44","slug":"wetenschappelijk-comite","status":"publish","type":"page","link":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/","title":{"rendered":"Wetenschappelijk comit\u00e9"},"content":{"rendered":"\n<nav aria-label=\"Breadcrumb\" class=\"wp-block-group aa-breadcrumb is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"aa-inner\"><a href=\"\/\">Home<\/a><span class=\"aa-breadcrumb__sep\">\u203a<\/span><a href=\"https:\/\/www.amyloidosisalliance.org\/about-us\/\">De Alliantie<\/a><span class=\"aa-breadcrumb__sep\">\u203a<\/span><span class=\"aa-breadcrumb__current\">Wetenschappelijk comit\u00e9<\/span><\/div>\n<\/nav>\n\n<section class=\"wp-block-group aa-page-hero is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-page-hero__grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-overline wp-block-paragraph\">De Alliantie<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Wetenschappelijk comit\u00e9<\/h1>\n\n\n\n<p class=\"aa-lead wp-block-paragraph\">Maak kennis met de vooraanstaande artsen en onderzoekers die de medische prioriteiten van de Alliantie sturen en onze publicaties valideren.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-page-hero__photo is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1710\" height=\"1698\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\" alt=\"\" class=\"wp-image-757\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg 1710w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-300x298.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-1024x1017.jpg 1024w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-150x150.jpg 150w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-768x763.jpg 768w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602-1536x1525.jpg 1536w\" sizes=\"auto, (max-width: 1710px) 100vw, 1710px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section class=\"wp-block-group aa-anchorband aa-anchorband--stats is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-columns aa-anchor-cols is-layout-flex wp-container-core-columns-is-layout-b2e659ba wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column aa-anchor-item is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"num wp-block-paragraph\">8<\/p>\n\n\n\n<p class=\"lbl wp-block-paragraph\">Experts<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-column aa-anchor-item is-layout-flow wp-block-column-is-layout-flow\">\n<p class=\"num wp-block-paragraph\">6<\/p>\n\n\n\n<p class=\"lbl wp-block-paragraph\">Landen<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section id=\"committee\" class=\"wp-block-group aa-section aa-section--cream aa-sc is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-team-head is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-eyebrow wp-block-paragraph\">Medische expertise<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Wie zij zijn<\/h2>\n<\/div>\n\n\n\n<p class=\"aa-team-head__text wp-block-paragraph\">Acht artsen en onderzoekers uit zes landen, die de verschillende gezichten van amylo\u00efdose bestrijken: cardiaal, hematologisch, neurologisch, renaal en inflammatoir.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/julian-gillmore.jpg\" alt=\"Julian Gillmore, portret\" class=\"wp-image-634\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/julian-gillmore.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/julian-gillmore-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/julian-gillmore-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Verenigd Koninkrijk<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Julian Gillmore<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Professor Julian Gillmore is hoogleraar geneeskunde aan University College London en honorair consultant-nefroloog in het Royal Free Hospital. Hij leidt het UCL Centre for Amyloidosis en is onderzoeksleider van het Britse National Amyloidosis Centre. Hij werd opgeleid in de nefrologie en behaalde zowel een MD als een PhD op het gebied van amylo\u00efdose. Zijn onderzoek richt zich op de pathogenese, diagnose en behandeling van systemische amylo\u00efdose, met bijzondere expertise in transthyretine-amylo\u00efdose.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/monique-minnema.jpg\" alt=\"Monique Minnema, portret\" class=\"wp-image-635\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/monique-minnema.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/monique-minnema-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/monique-minnema-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Nederland<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Monique Minnema<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Professor Monique Minnema is hoogleraar hematologie en internist-hematoloog in het UMC Utrecht. Zij is gespecialiseerd in B-celmaligniteiten, in het bijzonder plasmaceldyscrasie\u00ebn zoals multipel myeloom en AL-amylo\u00efdose, en in de ziekte van Waldenstr\u00f6m (macroglobulinemie). Zij leidt het klinische onderzoeksteam hematologie en de hematologische biobank van het UMC Utrecht. Haar klinisch onderzoek richt zich op de ontwikkeling van nieuwe cellulaire en medicamenteuze therapie\u00ebn voor plasmaceldyscrasie\u00ebn en andere B-celmaligniteiten.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/thibaud-damy.jpg\" alt=\"Thibaud Damy, portret\" class=\"wp-image-636\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/thibaud-damy.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/thibaud-damy-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/thibaud-damy-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Frankrijk<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Thibaud Damy<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Professor Thibaud Damy is hoogleraar cardiologie en hoofd van de afdeling hartfalen en cardiomyopathie\u00ebn van de Assistance Publique-H\u00f4pitaux de Paris. Hij leidt ook het Franse expertisecentrum voor cardiale amylo\u00efdose binnen het Cardiogen-netwerk. In 2009 richtte hij het Mondor Amyloidosis Network op, een multidisciplinaire structuur gewijd aan de diagnose en behandeling van amylo\u00efdose. Zijn klinisch werk en onderzoek richten zich op hartfalen en cardiale amylo\u00efdose, waaronder vroege diagnose, beeldvorming, biomarkers en behandeling. Sinds 2010 co\u00f6rdineert hij het R\u00e9seau Amylose, het Franse nationale netwerk voor zorg en doorverwijzing bij amylo\u00efdose, en daarnaast is hij medeco\u00f6rdinator van het klinische onderzoeksnetwerk F-CRIN GRACE, gewijd aan cardiale amylo\u00efdose.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/laura-obici.jpg\" alt=\"Laura Obici, portret\" class=\"wp-image-637\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/laura-obici.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/laura-obici-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/laura-obici-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Itali\u00eb<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Laura Obici<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Dr. Laura Obici is consultant-arts bij de afdeling zeldzame ziekten en het centrum voor onderzoek en behandeling van amylo\u00efdose van het IRCCS Fondazione Policlinico San Matteo in Pavia (Itali\u00eb). Haar klinische en onderzoeksactiviteiten richten zich op systemische amylo\u00efdose, waaronder erfelijke transthyretine-amylo\u00efdose en inflammatoire amylo\u00efdose. Zij heeft ruime ervaring met de diagnose en behandeling van erfelijke vormen van amylo\u00efdose en heeft bijgedragen aan internationaal onderzoek en klinische studies op dit gebied.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/fabio-fernandes.jpg\" alt=\"F&#xE1;bio Fernandes, portret\" class=\"wp-image-638\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/fabio-fernandes.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/fabio-fernandes-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/fabio-fernandes-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Brazili\u00eb<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">F\u00e1bio Fernandes<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Dr. F\u00e1bio Fernandes is universitair docent cardiologie aan de medische faculteit van de Universiteit van S\u00e3o Paulo en hoofd van de afdeling cardiomyopathie\u00ebn van het Hartinstituut (InCor) van de Universiteit van S\u00e3o Paulo, Brazili\u00eb. Zijn klinische en onderzoeksactiviteiten richten zich op cardiomyopathie\u00ebn, hartfalen en cardiale amylo\u00efdose, met bijzondere expertise in transthyretine-amylo\u00efde cardiomyopathie. Hij heeft ruime ervaring met de diagnose en behandeling van pati\u00ebnten met cardiale amylo\u00efdose en heeft bijgedragen aan talrijke nationale en internationale onderzoeksinitiatieven op dit gebied.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/sophie-georgin-lavialle.jpg\" alt=\"Sophie Georgin-Lavialle, portret\" class=\"wp-image-639\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/sophie-georgin-lavialle.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/sophie-georgin-lavialle-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/sophie-georgin-lavialle-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Frankrijk<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Sophie Georgin-Lavialle<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Professor Sophie Georgin-Lavialle is hoogleraar interne geneeskunde en klinische immunologie aan Sorbonne Universit\u00e9 en in het H\u00f4pital Tenon (AP-HP) in Parijs. Zij co\u00f6rdineert het onderdeel voor volwassenen van het Franse expertisecentrum voor auto-inflammatoire ziekten en inflammatoire amylo\u00efdose. Haar klinische en onderzoeksactiviteiten richten zich op auto-inflammatoire ziekten, waaronder familiaire mediterrane koorts, het VEXAS-syndroom en AA-amylo\u00efdose. Sinds 2025 is zij verantwoordelijk voor het domein auto-inflammatoire ziekten binnen het Europese referentienetwerk ERN RITA.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/pablo-garcia-pavia.jpg\" alt=\"Pablo Garc&#xED;a-Pav&#xED;a, portret\" class=\"wp-image-640\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/pablo-garcia-pavia.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/pablo-garcia-pavia-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/pablo-garcia-pavia-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Spanje<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">Pablo Garc\u00eda-Pav\u00eda<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Dr. Garc\u00eda-Pav\u00eda is hoofd van de afdeling hartfalen en erfelijke hartziekten van de dienst cardiologie van het Hospital Universitario Puerta de Hierro in Madrid. Naast zijn werk in het ziekenhuis is hij ook onderzoekshoogleraar aan het Spaanse nationale onderzoeksinstituut (CNIC) en adjunct-hoofdredacteur van de Revista Espa\u00f1ola de Cardiolog\u00eda. Zijn onderzoek richt zich onder meer op erfelijke cardiomyopathie\u00ebn, hartfalen en amylo\u00efdose, en hij heeft meer dan 350 artikelen gepubliceerd in tijdschriften met peerreview, waaronder The New England Journal of Medicine, European Heart Journal, Journal of the American College of Cardiology, Circulation, Nature Communications, Nature Medicine en The Lancet.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-sc-card is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-sc-card__head is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full aa-sc-card__photo\"><img loading=\"lazy\" decoding=\"async\" width=\"640\" height=\"640\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/marcia-waddington-cruz.jpg\" alt=\"M&#xE1;rcia Waddington-Cruz, portret\" class=\"wp-image-641\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/marcia-waddington-cruz.jpg 640w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/marcia-waddington-cruz-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/marcia-waddington-cruz-150x150.jpg 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/figure>\n\n\n\n<div class=\"wp-block-group aa-sc-card__id is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__country wp-block-paragraph\">Brazili\u00eb<\/p>\n\n\n\n<h3 class=\"wp-block-heading aa-sc-card__name\">M\u00e1rcia Waddington-Cruz<\/h3>\n\n\n\n<div class=\"wp-block-group aa-sc-card__meta is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-sc-card__deg wp-block-paragraph\">MD, PhD<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<p class=\"aa-sc-card__bio wp-block-paragraph\">Dr. M\u00e1rcia Waddington-Cruz behaalde een master en een PhD in de neurologie aan de FM-UFRJ en is specialist in de klinische neurofysiologie, gecertificeerd door de SBNC\/AMB. Zij is hoogleraar in het postdoctorale programma klinische geneeskunde van de FM-UFRJ, de Federale Universiteit van Rio de Janeiro. Zij is hoofdonderzoeker bij het CEPARM-expertisecentrum voor amylo\u00efdose van het universitair ziekenhuis van de UFRJ, co\u00f6rdinator van het zorgtraject amylo\u00efdose van het ziekenhuiscomplex Am\u00e9ricas-Vit\u00f3ria-Samaritano Barra (Rio de Janeiro) en hoofdonderzoeker bij het American Institute of Science and Education.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section class=\"wp-block-group aa-next aa-next--split is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-next__head is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-section-num wp-block-paragraph\">Verder lezen<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Ontdek de Alliantie<\/h2>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-next__grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-next-card is-layout-flow wp-block-group-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.amyloidosisalliance.org\/the-team\/\">Het team<\/a><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Maak kennis met het bestuur, het uitvoerend team en de werkgroepen die de Alliantie dagelijks draaiende houden.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-next-card is-layout-flow wp-block-group-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.amyloidosisalliance.org\/our-missions\/\">Onze missies<\/a><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ontdek de acties die de Alliantie onderneemt om de diagnose, de zorg en de erkenning van amylo\u00efdose te verbeteren.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-next-card is-layout-flow wp-block-group-is-layout-flow\">\n<h3 class=\"wp-block-heading\"><a href=\"https:\/\/www.amyloidosisalliance.org\/nl\/informatiebronnen\/bibliotheek\/\">Bibliotheek<\/a><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Blader door de gevalideerde gidsen, informatiebladen en hulpmiddelen die voor pati\u00ebnten en zorgverleners zijn gemaakt.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Home\u203aDe Alliantie\u203aWetenschappelijk comit\u00e9 De Alliantie Wetenschappelijk comit\u00e9 Maak kennis met de vooraanstaande artsen en onderzoekers die de medische prioriteiten van de Alliantie sturen en onze publicaties valideren. 8 Experts 6 Landen Medische expertise Wie zij zijn Acht artsen en onderzoekers uit zes landen, die de verschillende gezichten van amylo\u00efdose bestrijken: cardiaal, hematologisch, neurologisch, renaal en [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3619","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Experts in amylo\u00efdose: ons wetenschappelijk comit\u00e9<\/title>\n<meta name=\"description\" content=\"Artsen en onderzoekers uit zes landen sturen de medische prioriteiten van de Alliantie en lezen de informatie op deze website na.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Experts in amylo\u00efdose: ons wetenschappelijk comit\u00e9\" \/>\n<meta property=\"og:description\" content=\"Artsen en onderzoekers uit zes landen sturen de medische prioriteiten van de Alliantie en lezen de informatie op deze website na.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/\" \/>\n<meta property=\"og:site_name\" content=\"Amyloidosis Alliance\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmyloidosisAlliance\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-03T07:38:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1710\" \/>\n\t<meta property=\"og:image:height\" content=\"1698\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/wetenschappelijk-comite\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/wetenschappelijk-comite\\\/\",\"name\":\"Experts in amylo\u00efdose: ons wetenschappelijk comit\u00e9\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/wetenschappelijk-comite\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/wetenschappelijk-comite\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\",\"datePublished\":\"2026-09-04T07:15:43+00:00\",\"dateModified\":\"2026-11-03T07:38:44+00:00\",\"description\":\"Artsen en onderzoekers uit zes landen sturen de medische prioriteiten van de Alliantie en lezen de informatie op deze website na.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/wetenschappelijk-comite\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/wetenschappelijk-comite\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/wetenschappelijk-comite\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/wetenschappelijk-comite\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wetenschappelijk comit\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#website\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/\",\"name\":\"Amyloidosis Alliance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#organization\",\"name\":\"Amyloidosis Alliance\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"width\":252,\"height\":252,\"caption\":\"Amyloidosis Alliance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmyloidosisAlliance\\\/\",\"https:\\\/\\\/x.com\\\/amyloidosisa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Experts in amylo\u00efdose: ons wetenschappelijk comit\u00e9","description":"Artsen en onderzoekers uit zes landen sturen de medische prioriteiten van de Alliantie en lezen de informatie op deze website na.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/","og_locale":"nl_NL","og_type":"article","og_title":"Experts in amylo\u00efdose: ons wetenschappelijk comit\u00e9","og_description":"Artsen en onderzoekers uit zes landen sturen de medische prioriteiten van de Alliantie en lezen de informatie op deze website na.","og_url":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/","og_site_name":"Amyloidosis Alliance","article_publisher":"https:\/\/www.facebook.com\/AmyloidosisAlliance\/","article_modified_time":"2026-11-03T07:38:44+00:00","og_image":[{"width":1710,"height":1698,"url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@amyloidosisa","twitter_misc":{"Geschatte leestijd":"4 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/","url":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/","name":"Experts in amylo\u00efdose: ons wetenschappelijk comit\u00e9","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/#primaryimage"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/#primaryimage"},"thumbnailUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg","datePublished":"2026-09-04T07:15:43+00:00","dateModified":"2026-11-03T07:38:44+00:00","description":"Artsen en onderzoekers uit zes landen sturen de medische prioriteiten van de Alliantie en lezen de informatie op deze website na.","breadcrumb":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/#primaryimage","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/national-cancer-institute-6NMcUDG37Yc-unsplash-scaled-e1788766655602.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/wetenschappelijk-comite\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.amyloidosisalliance.org\/nl\/home\/"},{"@type":"ListItem","position":2,"name":"Wetenschappelijk comit\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#website","url":"https:\/\/www.amyloidosisalliance.org\/nl\/","name":"Amyloidosis Alliance","description":"","publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.amyloidosisalliance.org\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#organization","name":"Amyloidosis Alliance","url":"https:\/\/www.amyloidosisalliance.org\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","width":252,"height":252,"caption":"Amyloidosis Alliance"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmyloidosisAlliance\/","https:\/\/x.com\/amyloidosisa"]}]}},"_links":{"self":[{"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/pages\/3619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/comments?post=3619"}],"version-history":[{"count":2,"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/pages\/3619\/revisions"}],"predecessor-version":[{"id":3633,"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/pages\/3619\/revisions\/3633"}],"wp:attachment":[{"href":"https:\/\/www.amyloidosisalliance.org\/nl\/wp-json\/wp\/v2\/media?parent=3619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}